welcome
The Motley Fool

The Motley Fool

Health

Health

Is Merck Stock a Bargain Buy?

The Motley Fool
Summary
Nutrition label

70% Informative

Merck ( NYSE : MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda .

Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? While there is some uncertainty around Merck , I find the company's pipeline promising, and I think the moves management making are encouraging.

- Apple: if you invested $ 1,000 when we doubled down in 2008 , you’d have $ 42,421 !

- Netflix: if you invested $ 1,000 when we doubled down in 2004 , you’d have $ 537,825 !

Right now, we’re issuing “ Double Down ” alerts for three incredible companies, and there may not be another chance like this anytime soon.

Stock Advisor returns as of March 24, 2025 Is Merck Stock a Bargain Buy? was originally published by The Motley Fool .

VR Score

66

Informative language

64

Neutral language

13

Article tone

informal

Language

English

Language complexity

36

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links